Caroline Robert on treatments for patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN trial)
de
The Lancet Oncology in conversation with
2025-05-28 22:00:00
Fecha de lanzamiento
10:45
Duración
